ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 130 filers reported holding ANAPTYSBIO INC in Q1 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $444,000 | -45.3% | 6,082 | -52.2% | 0.18% | -59.0% |
| Q4 2018 | $812,000 | +149.1% | 12,734 | +306.8% | 0.43% | +251.6% |
| Q1 2018 | $326,000 | -66.6% | 3,130 | -67.7% | 0.12% | -59.2% |
| Q4 2017 | $977,000 | +13.6% | 9,700 | -60.6% | 0.30% | +14.6% |
| Q3 2017 | $860,000 | +233.3% | 24,600 | +164.5% | 0.26% | +214.5% |
| Q1 2017 | $258,000 | – | 9,300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $371,500,000 | 60.25% |
| Cormorant Asset Management, LP | 1,251,485 | $126,050,000 | 13.20% |
| BVF INC/IL | 594,397 | $59,868,000 | 7.22% |
| VHCP Management II, LLC | 282,550 | $28,458,000 | 6.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 812,484 | $81,833,000 | 3.22% |
| Iguana Healthcare Management, LLC | 40,000 | $4,029,000 | 2.62% |
| Perceptive Advisors | 756,387 | $76,183,000 | 2.52% |
| Cormorant Asset Management, LP | 135,000 | $13,597,000 | 1.42% |
| EAM Global Investors LLC | 21,734 | $2,189,000 | 1.12% |
| PFM Health Sciences, LP | 425,896 | $42,896,000 | 1.02% |